Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide

Maarten Leening

doi:10.1001/jamacardio.2019.3528

Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide

Research output: Contribution to journal › Editorial › Academic

1 Citation (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1075-1076
Number of pages	2
Journal	JAMA Cardiology
Volume	4
Issue number	11
DOIs	https://doi.org/10.1001/jamacardio.2019.3528
Publication status	Published - 2019

Research programs

EMC COEUR-09

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamacardio.2019.3528

Cite this

@article{4d04a3b5613f40f99f4d4feff265153a,

title = "Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide",

author = "Maarten Leening",

year = "2019",

doi = "10.1001/jamacardio.2019.3528",

language = "Undefined/Unknown",

volume = "4",

pages = "1075--1076",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide

AU - Leening, Maarten

PY - 2019

Y1 - 2019

U2 - 10.1001/jamacardio.2019.3528

DO - 10.1001/jamacardio.2019.3528

M3 - Editorial

C2 - 31553411

SN - 2380-6583

VL - 4

SP - 1075

EP - 1076

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 11

ER -